Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-23T13:55:11.616Z Has data issue: false hasContentIssue false
  • English
  • Français

The Efficacy and Safety Profile of a New Antipsychotic, Ziprasidone

Published online by Cambridge University Press:  16 April 2020

R. O’Connor ,
E. Harrigan ,
J. Heym ,
G. Ko  and
L. Chandler
R. O’Connor
Affiliation:
Pfizer Central Research. Sandwich. Kent. CTJ3 9NJ. UK
E. Harrigan
Affiliation:
Pfizer Central Research, Groton. CT06340. USA
J. Heym
Affiliation:
Pfizer Central Research, Groton. CT06340. USA
G. Ko
Affiliation:
international Pharmaceuticals Group. PfizerInc. New York. NY10017. USA
L. Chandler
Affiliation:
Pfizer Central Research, Groton. CT06340. USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Poster Presentations
Information
European Psychiatry , Volume 11 , Issue S4: European psychiatry: a force for the future - 8th Congress of Association of European Psychiatrists and Annual Meeting of the Royal College of Psychiatrists , 1996 , pp. 420s
Copyright
Copyright © Elsevier Paris 1996
Submit a response

Comments

No Comments have been published for this article.